| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tarek Sawas, Fateh Bazerbachi, Samir Haffar, Won K Cho, Michael Levy, John A Martin, Bret T Petersen, Mark Topazian, Vinay Chandrasekhara and Barham K Abu Dayyeh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Barham K Abu Dayyeh, MD, Associate Professor, Attending Doctor, Director, Director, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, 200 First Ave., S.W., Rochester, MN 55905, United States. abudayyeh.barham@mayo.edu |
| Key Words |
End-stage renal disease; Nationwide Inpatient Sample; Endoscopic retrograde cholangiopancreatography |
| Core Tip |
Recognizing risk factors for endoscopic retrograde cholangiopancreatography (ERCP)-related complications is essential to reduce adverse events (AEs). There are limited data evaluating ERCP outcomes in renal disease. In a retrospective cohort study using the Nationwide Inpatient Sample 2011-2013 and including 492175 discharges, we compared inpatient ERCP AEs, mortality and length of stay between patients with and without renal disease. We found end-stage renal disease (ESRD) to be associated with higher post ERCP pancreatitis [8.3%, adjusted odd ratio (aOR) = 1.7, aP < 0.001], bleeding (5.1%, aOR = 1.86, aP < 0.001), mortality (7.1%, aOR = 6.6, aP < 0.001) and longer hospital stay (5.9 d, aP < 0.001). Physicians should consider special interventions in ESRD patients to decrease ERCP AEs. |
| Publish Date |
2018-11-07 02:30 |
| Citation |
Sawas T, Bazerbachi F, Haffar S, Cho WK, Levy MJ, Martin JA, Petersen BT, Topazian MD, Chandrasekhara V, Abu Dayyeh BK. End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients. World J Gastroenterol 2018; 24(41): 4691-4697 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i41/4691.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i41.4691 |
